Monday, March 15, 2010
ADXS Develops New Sorage For Listeria
NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)-Advaxis Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company has developing a long-term, room temperature, storage-stable form of its vaccines. This would replace the current requirement to keep the product frozen at -70o C before use.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment